Pharmaceutical Manufacturing and Packing Sourcer |
 |
|
|
|
|
 |
| |
|
|
|
|
|
Are You Ready for the Drug Supply Chain Security Act?
Matt Sample at AmerisourceBergen
The DSCSA was enacted in 2013; however, pharma manufacturers must comply to new implementations in an effort to make the supply chain even more secure.
|
|
|
|
Counterfeiting: At What Cost?
Christoph Krähenbühl at Excellis Europe
Counterfeit drugs can cause adverse effects not just to the end user, but also for legitimate manufacturers trying to get their products to market.
|
|
|
|
|
ASEAN Pharma Report: Opportunities and Threats 2020 and Beyond
Informa Markets
Does pharma manufacturing in South East Asia live up to EU-GMP and WHO-GMP manufacturing standards?
|
|
|
|
Similarities and Differences in Extractable Testing
Andrew Feilden at Hall Analytical
Protecting humans from thecbiological risks arising from the use of medical devices is paramount, so many factors must be taken into consideration when designing extractable and leachable studies.
|
|
|
|
Qualification of Pharmaceutical Shipping Systems in Seven Steps
Dr Erik J van Asselt at MSD
Dr Zvonimir Majic at Teva Pharmaceuticals
Dr Rafik H Bishara at Eli Lilly and Company (retired)
Eric Stener at Sanofi Pasteur
To help tackle disturbances in the supply chain, pharmaceutical shipping systems should be employed to ensure the efficacy of the products being transported.
|
|
|
|
Electrostatic Hazards in Pneumatic Conveying Systems
James Grimshaw at Newson Gale
Adopting a technology-based approach in the manufacturing process is key to protecting your workforce and company from the consequences of an electrostatic ignition.
|
|
|
|
|
|
Are Tablets Still Relevant?
Dr Dave Berry at CPI
Although tablet manufacture may be in decline, its lower production costs and simplicity to manufacture may be making it a serious contender in meeting unmet medical needs.
|
|
|
|
The Mass Production of Tablets
Marianna D’Onghia at I Holland
Manufacturing methods must be addressed when exploring how to meet consumer demand in the manufacturing of tablets.
|
|
|
|
The Growing Popularity of Capsule Manufacturing in Pharma
Stephen Byard at Arcinova
Compounded pharmaceutical formulations can take much longer to develop than simple capsule formulations, and this may be the reason for their growing popularity, especially in circumstances where acceleration to early-phase clinical trials is a priority.
|
|
|
|
|
Four Challenges for Pharma 4.0
Mark Bouch at Leading Change
PMPS kicks off with an exploration into whether augmented technologies and artificial intelligence will help or hinder current workforces.
|
|
|
|
Tangible Technology
Amy Shortman at Overhaul
The pharmaceutical industry is notorious for being slow to adopt Industry 4.0, but implementing these technologies can bring a wealth of benefits to the supply chain.
|
|
|
|
Secure, Collaborative Technologies Throughout the Pharmaceutical Supply Chain
Jason Lacombe at Veratrak
Collaboration in the supply chain is essential, and the life science industry is beginning to embrace new technologies to help combat the unique challenges it faces.
|
|
|
|
New, Emerging Industrial Digital Technologies
Alwyn Jones at Siemens Digital Industries
In an industry where reliability, consistency, and safety are of the utmost importance, pharma cannot ignore the role that digitisation plays in ensuring these ends are met.
|
|
|
|
|
Preparing for a World in Flux
Rich Quelch at Origin
The pharma industry is part of the problem, but it can also be a part of the solution when it comes to minimising climate change.
|
|
|
|
Utilising Reusable, Real-Time Technology to Reduce Supply Chain Waste
Ada Palmadottir at Controlant
The employment of reusable real-time technology is making it possible for companies to track and reduce their carbon footprint.
|
|
|
|
Sustainability in Healthcare Packaging
Dieter Mößner at Edelmann Group
Efforts should be made so the primary, secondary, and tertiary packaging of pharmaceutical products are as environmentally friendly as possible.
|
|
|
|
Steps to More Sustainable Packaging
Niels Düring at Gerresheimer
In this Q&A, we discover if 100% recyclable pharma packaging is a realistic probability.
|
|
|
|
|
|
